Livforsakringsbolaget Skandia, Omsesidigt Jazz Pharmaceuticals PLC Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$115.94 - $166.74 $2.22 Million - $3.2 Million	-19,180 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$161.01 - $180.57 $660,141 - $740,337	-4,100 Reduced 17.61%	19,180 $3.23 Million
Q4 2017 Jan 18, 2018	SELL	$131.06 - $150.39 $222,802 - $255,662	-1,700 Reduced 6.81%	23,280 $3.13 Million
Q3 2017 Oct 12, 2017	BUY	$142.62 - $155.6 $3.56 Million - $3.89 Million	24,980	24,980 $3.65 Million

514

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.8B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.